French Adaptation of the AIDA (Assessment of Identity Development in Adolescence) and LoPF-Q (Levels of Personality Functioning Questionnaire) Scales.

• ClinicalTrials.gov Identifier: NCT04692350
• Recruitment Status: Completed
• First Posted: December 31, 2020
• Last Update Posted: October 19, 2021
• Sponsor: University Hospital, Montpellier
• Information provided by (Responsible Party): University Hospital, Montpellier

Study Description

Brief Summary:

The main objective of this study is to develop the French version of the two questionnaires AIDA and LoPF-Q. The secondary objective is to investigate the links between disrupted development of identity and adolescent psychopathology.

To participate in the study, patients will have to complete online or paper versions of the questionnaires AIDA-LoPF and other assessments of personality and general psychopathology (BB5, SDQ). Parents will have to answer complete the parent version of the SDQ questionnaire. The BPFSC-11, which is a clinician-rated assessment, will be completed in a subgroup of patients, by the same healthcare professional, in order to assess the concurrent validity. The investigators will also add the clinical diagnoses according to ICD-10 found in the medical record.

Condition or disease
Personality Disorders; Borderline Personality Disorder

Detailed Description:

A personality disorder is a lasting mode of behavior and lived experience that deviates significantly from what is expected in the culture of the individual is invasive and rigid, appears in early adolescence or adulthood, is stable over time and is a source of distress or impaired functioning.

Most of the tools for assessing high-risk personality disorders and traits have been developed in adults.Yet it is important to have effective tools to distinguish personality disorders from other mental disorders as early as possible. The identification of young people at high risk of personality disorders allows their rapid referral to appropriate psychotherapies.

The AIDA and LoPF-Q, screening questionnaires, were recently developed to include an assessment of personality functioning in the process of diagnosing emotional and behavioral disorders in adolescence. They have been tested in several countries such as Germany, USA, Mexico, Croatia… The results of the studies show that AIDA and LoPF questionnaires are reliable and valid instruments for assessing normal and disturbed identity in adolescents and distinguishes well between patients with psychiatric illnesses and healthy controls.

Study Design

• Study Type: Observational
• Actual Enrollment: 100 participants
• Observational Model: Case-Control
• Time Perspective: Cross-Sectional
• Official Title: Adaptation française Des échelles AIDA (Assessment of Identity Development in Adolescence) et LoPF-Q (Levels of Personnality Functioning Questionnaire), Designed to Assess Personality Development in Adolescence.
• Actual Study Start Date: January 10, 2021
• Actual Primary Completion Date: June 30, 2021
• Actual Study Completion Date: September 30, 2021

Groups and Cohorts

Outcome Measures

Primary Outcome Measures :

1. number of Iinternal consistency [ Time Frame: 1 day ]
   Iinternal consistency (coefficient α) which is supposed to exceed 0.70 at the level of the scale and 0.60 at the level of the subscales.

Secondary Outcome Measures :

1. Number of Inter-item correlational structure (ACP) [ Time Frame: 1 day ]
   Inter-item correlational structure (ACP)
2. links to psychopathology (especially Borderline personality) [ Time Frame: 1 day ]
   links to psychopathology (especially Borderline personality)

Biospecimen Retention:   None Retained

NC

Eligibility Criteria

• Ages Eligible for Study: 12 Years to 18 Years (Child, Adult)
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No
• Sampling Method: Non-Probability Sample

Study Population

The population studied includes adolescents followed in psychiatry, whether they are hospitalized (UCAP or full hospitalization at MPEA Saint-Eloi in Montpellier) or followed on an outpatient basis (MPEAs Peyre Plantade and Saint-Eloi in Montpellier).

Criteria

Inclusion criteria:

• The adolescent must be between 12 and 18 years old
• be able (see non-inclusion criteria below) and agree to complete the various evaluations proposed, and not present a psychotic episode at the time. time of the questionnaires.
• The adolescent does not have to have any risky personality traits to participate in this study.

Exclusion criteria:

• insufficient levels of French and / or reading
• presence of an intellectual development disorder or a clinically proven current psychotic disorder,
• active or passive opposition of the patient and / or its legal representatives to participate in the study.

Contacts and Locations

Locations

France

Uhmontpellier

Montpellier, France, 34295

Sponsors and Collaborators

University Hospital, Montpellier

Investigators

• Principal Investigator: Diane Purper-Ouakil, M.D., Ph. D.; UH Montpellier

More Information

• Responsible Party: University Hospital, Montpellier
• ClinicalTrials.gov Identifier: NCT04692350
• Other Study ID Numbers: RECHMPL20_0621
• First Posted: December 31, 2020
• Last Update Posted: October 19, 2021
• Last Verified: October 2021

Individual Participant Data (IPD) Sharing Statement:

• Plan to Share IPD: Undecided
• Plan Description: NC

• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No

Keywords provided by University Hospital, Montpellier:

Adolescents; Questionnaires

Additional relevant MeSH terms:

Disease; Personality Disorders; Borderline Personality Disorder; Pathologic Processes; Mental Disorders